Autoreactive effector T cell (Teff) (Teff)

Autoreactive effector T cells are a specialized population of T lymphocytes that have escaped central and peripheral tolerance mechanisms, leading them to recognize self-antigens as foreign (StatPearls, 2023). These cells play a pivotal role in the initiation and progression of various autoimmune diseases by infiltrating target organs and secreting pro-inflammatory cytokines or directly killing host cells (PubMed, PMID: 31043410). In conditions such as Type 1 Diabetes and Multiple Sclerosis, these cells drive tissue destruction through the release of mediators like interferon-gamma and interleukin-17 (NIH, 2022). Therapeutic interventions often focus on selectively depleting these pathogenic populations or modulating their activity to restore immune homeostasis (Nature Reviews Immunology, 2020). Modern pharmacological approaches include monoclonal antibodies like Teplizumab that target T-cell receptors, as well as small molecules that interfere with intracellular signaling pathways essential for T-cell survival and function (FDA, 2022). Balancing the suppression of these autoreactive cells while maintaining protective immunity against pathogens remains a significant clinical challenge. Additionally, the identification of specific biomarkers on these cells allows for more targeted therapies that spare the broader immune system (PubMed, PMID: 28190768).

Other names

Self-reactive T cellPathogenic T cellAutoreactive T lymphocyteEffector T cell

Therapeutic strategies involve depleting these cells, inhibiting their activation by blocking costimulatory signals, or preventing their migration into target tissues (PubMed, PMID: 28190768). Some drugs act by inhibiting calcineurin to prevent cytokine production, while others use monoclonal antibodies to target specific surface receptors like CD3 or CD52 to induce cell death or functional exhaustion (StatPearls, 2023). Newer approaches also explore the induction of regulatory T cells to suppress these effector populations (Nature Reviews Immunology, 2020).